Loss of TET2 increases B-1 cell number and IgM production while limiting CDR3 diversity
Recent studies have demonstrated a role for Ten-Eleven Translocation-2 (TET2), an epigenetic modulator, in regulating germinal center formation and plasma cell differentiation in B-2 cells, yet the role of TET2 in regulating B-1 cells is largely unknown. Here, B-1 cell subset numbers, IgM production, and gene expression were analyzed in mice with global knockout of TET2 compared to wildtype (WT) controls. Results revealed that TET2-KO mice had elevated numbers of B-1a and B-1b cells in their primary niche, the peritoneal cavity, as well as in the bone marrow (B-1a) and spleen (B-1b). Consistent with this finding, circulating IgM, but not IgG, was elevated in TET2-KO mice compared to WT. Analysis of bulk RNASeq of sort purified peritoneal B-1a and B-1b cells revealed reduced expression of heavy and light chain immunoglobulin genes, predominantly in B-1a cells from TET2-KO mice compared to WT controls. As expected, the expression of IgM transcripts was the most abundant isotype in B-1 cells. Yet, only in B-1a cells there was a significant increase in the proportion of IgM transcripts in TET2-KO mice compared to WT. Analysis of the CDR3 of the BCR revealed an increased abundance of replicated CDR3 sequences in B-1 cells from TET2-KO mice, which was more clearly pronounced in B-1a compared to B-1b cells. V-D-J usage and circos plot analysis of V-J combinations showed enhanced usage of VH11 and VH12 pairings. Taken together, our study is the first to demonstrate that global loss of TET2 increases B-1 cell number and IgM production and reduces CDR3 diversity, which could impact many biological processes and disease states that are regulated by IgM..
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:15 |
|---|---|
| Enthalten in: |
Frontiers in Immunology - 15(2024) |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Emily Dennis [VerfasserIn] |
|---|
| Links: |
doi.org [kostenfrei] |
|---|
| Themen: |
B cell receptor (BCR) |
|---|
| doi: |
10.3389/fimmu.2024.1380641 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
DOAJ100905404 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | DOAJ100905404 | ||
| 003 | DE-627 | ||
| 005 | 20240414132146.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 240414s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.3389/fimmu.2024.1380641 |2 doi | |
| 035 | |a (DE-627)DOAJ100905404 | ||
| 035 | |a (DE-599)DOAJe381fe19acd54eb697d2fdd0ef3acea1 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 050 | 0 | |a RC581-607 | |
| 100 | 0 | |a Emily Dennis |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Loss of TET2 increases B-1 cell number and IgM production while limiting CDR3 diversity |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 520 | |a Recent studies have demonstrated a role for Ten-Eleven Translocation-2 (TET2), an epigenetic modulator, in regulating germinal center formation and plasma cell differentiation in B-2 cells, yet the role of TET2 in regulating B-1 cells is largely unknown. Here, B-1 cell subset numbers, IgM production, and gene expression were analyzed in mice with global knockout of TET2 compared to wildtype (WT) controls. Results revealed that TET2-KO mice had elevated numbers of B-1a and B-1b cells in their primary niche, the peritoneal cavity, as well as in the bone marrow (B-1a) and spleen (B-1b). Consistent with this finding, circulating IgM, but not IgG, was elevated in TET2-KO mice compared to WT. Analysis of bulk RNASeq of sort purified peritoneal B-1a and B-1b cells revealed reduced expression of heavy and light chain immunoglobulin genes, predominantly in B-1a cells from TET2-KO mice compared to WT controls. As expected, the expression of IgM transcripts was the most abundant isotype in B-1 cells. Yet, only in B-1a cells there was a significant increase in the proportion of IgM transcripts in TET2-KO mice compared to WT. Analysis of the CDR3 of the BCR revealed an increased abundance of replicated CDR3 sequences in B-1 cells from TET2-KO mice, which was more clearly pronounced in B-1a compared to B-1b cells. V-D-J usage and circos plot analysis of V-J combinations showed enhanced usage of VH11 and VH12 pairings. Taken together, our study is the first to demonstrate that global loss of TET2 increases B-1 cell number and IgM production and reduces CDR3 diversity, which could impact many biological processes and disease states that are regulated by IgM. | ||
| 650 | 4 | |a innate B cells | |
| 650 | 4 | |a B-1 cells | |
| 650 | 4 | |a ten-eleven translocation-2 (TET2) | |
| 650 | 4 | |a natural antibodies (Nab) | |
| 650 | 4 | |a immunoglobulin M (IgM) | |
| 650 | 4 | |a B cell receptor (BCR) | |
| 653 | 0 | |a Immunologic diseases. Allergy | |
| 700 | 0 | |a Emily Dennis |e verfasserin |4 aut | |
| 700 | 0 | |a Maria Murach |e verfasserin |4 aut | |
| 700 | 0 | |a Maria Murach |e verfasserin |4 aut | |
| 700 | 0 | |a Cassidy M.R. Blackburn |e verfasserin |4 aut | |
| 700 | 0 | |a Melissa Marshall |e verfasserin |4 aut | |
| 700 | 0 | |a Katherine Root |e verfasserin |4 aut | |
| 700 | 0 | |a Tanyaporn Pattarabanjird |e verfasserin |4 aut | |
| 700 | 0 | |a Justine Deroissart |e verfasserin |4 aut | |
| 700 | 0 | |a Loren D. Erickson |e verfasserin |4 aut | |
| 700 | 0 | |a Loren D. Erickson |e verfasserin |4 aut | |
| 700 | 0 | |a Christoph J. Binder |e verfasserin |4 aut | |
| 700 | 0 | |a Stefan Bekiranov |e verfasserin |4 aut | |
| 700 | 0 | |a Stefan Bekiranov |e verfasserin |4 aut | |
| 700 | 0 | |a Coleen A. McNamara |e verfasserin |4 aut | |
| 700 | 0 | |a Coleen A. McNamara |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i In |t Frontiers in Immunology |d Frontiers Media S.A., 2011 |g 15(2024) |w (DE-627)DOAJ000031690 |x 16643224 |7 nnns |
| 773 | 1 | 8 | |g volume:15 |g year:2024 |
| 856 | 4 | 0 | |u https://doi.org/10.3389/fimmu.2024.1380641 |z kostenfrei |
| 856 | 4 | 0 | |u https://doaj.org/article/e381fe19acd54eb697d2fdd0ef3acea1 |z kostenfrei |
| 856 | 4 | 0 | |u https://www.frontiersin.org/articles/10.3389/fimmu.2024.1380641/full |z kostenfrei |
| 856 | 4 | 2 | |u https://doaj.org/toc/1664-3224 |y Journal toc |z kostenfrei |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_DOAJ | ||
| 951 | |a AR | ||
| 952 | |d 15 |j 2024 | ||